Corcept Therapeutics OverviewCorcept Therapeutics Other Income Expense Net
Other Income/Expense Net for CORT.
Quarterly Other Income/Expense
$4.89M
↓ 21.22% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$20.35M
↓ 19.4% YoY
Trailing 12 months ending Mar 31, 2026